Regulatory Approvals

Press Release Service: Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia

By

Regulatory Approvals — Press Release Service: Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia  CRISPR Medicine News

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. July 26, 2026.

By

Related Post

Regulatory Approvals

Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics?

Regulatory Approvals

FDA approves new over-the-counter pain relief

Regulatory Approvals

FDA Approves LYTENAVA, First Ophthalmic Bevacizumab for Wet AMD

Financial News For All

Business Economy Finance

Commodities Price Update: Crude Oil $89.31, Brent $96.78, Copper $6.36, Coal $104.75 — Jul 26, 2026 8:00 AM EDT

Product Recalls

BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION

Product Recalls

OeyUoc Pool Drain Covers Recalled Due to Risk of Serious Injury or Death from Entrapment and Drowning Hazards; Violate Virginia Graeme Baker Pool & Spa Safety Act; Sold Exclusively on Amazon by Yuanxinxiang

Product Recalls

Sviyatp Pool Drain Covers Recalled Due to Risk of Serious Injury or Death from Entrapment and Drowning Hazards; Violate Virginia Graeme Baker Pool & Spa Safety Act